Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joan How

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
American Journal of Hematology|August 26, 2018
Prognostic value of prior consolidation in acute myeloid leukemia patients undergoing hematopoietic cell transplantation in minimal residual disease-negative first complete remissionJoan How, Kiran R Vij, Maryam Ebadi, et al.
Leukemia|February 26, 2022
Antibody and T-cell responses to SARS-CoV-2 vaccination in myeloproliferative neoplasm patientsJoan How, Kathleen M E Gallagher, Yiwen Liu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 15, 2017
T Cell-Replete Peripheral Blood Haploidentical Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide Results in Outcomes Similar to Transplantation from Traditionally Matched Donors in Active Disease Acute Myeloid LeukemiaJoan How, Michael Slade, Khoan Vu, et al.
Leukemia & Lymphoma|March 5, 2026
Ruxolitinib and heart failure outcomes among patients with myelofibrosisOrly Leiva, Steven Soo, Olivia C Liu, et al.
Cardio-Oncology (London, England)|March 12, 2026
Echocardiographic high-output heart failure is associated with worse survival among patients with myelofibrosisOrly Leiva, Steven Soo, Olivia C Liu, et al.
Blood Advances|March 4, 2026
Low Serum Cholesterol Is a Biomarker of Advanced Disease and Poor Outcomes in Myeloproliferative NeoplasmsOrly Leiva, Steven Soo, Olivia C Liu, et al.
Leukemia Research|October 6, 2020
Pregnancy outcomes, risk factors, and cell count trends in pregnant women with essential thrombocythemiaJoan How, Orly Leiva, Thomas Bogue, et al.
Blood Advances|January 7, 2026
Impact of Statin Use on Cardiovascular and Hematologic Outcomes Among Patients with Myeloproliferative NeoplasmsOrly Leiva, Steven Soo, Olivia C Liu, et al.
Blood Vessels, Thrombosis & Hemostasis|August 6, 2025
Cardiovascular risk factors in myeloproliferative neoplasms: associations with survival and thrombotic outcomesJoan How, Orly Leiva, Robert Redd, et al.
JACC. Cardiooncology|July 16, 2025
Beyond Thrombosis: Pulmonary Hypertension and Heart Failure in Patients With Myeloproliferative Neoplasms: JACC: CardioOncology State-of-the-Art ReviewOrly Leiva, Olivia Liu, Anthony Kanelidis, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
American Journal of Hematology|August 26, 2018
Prognostic value of prior consolidation in acute myeloid leukemia patients undergoing hematopoietic cell transplantation in minimal residual disease-negative first complete remissionJoan How, Kiran R Vij, Maryam Ebadi, et al.
Leukemia|February 26, 2022
Antibody and T-cell responses to SARS-CoV-2 vaccination in myeloproliferative neoplasm patientsJoan How, Kathleen M E Gallagher, Yiwen Liu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 15, 2017
T Cell-Replete Peripheral Blood Haploidentical Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide Results in Outcomes Similar to Transplantation from Traditionally Matched Donors in Active Disease Acute Myeloid LeukemiaJoan How, Michael Slade, Khoan Vu, et al.
Leukemia & Lymphoma|March 5, 2026
Ruxolitinib and heart failure outcomes among patients with myelofibrosisOrly Leiva, Steven Soo, Olivia C Liu, et al.
Cardio-Oncology (London, England)|March 12, 2026
Echocardiographic high-output heart failure is associated with worse survival among patients with myelofibrosisOrly Leiva, Steven Soo, Olivia C Liu, et al.
Blood Advances|March 4, 2026
Low Serum Cholesterol Is a Biomarker of Advanced Disease and Poor Outcomes in Myeloproliferative NeoplasmsOrly Leiva, Steven Soo, Olivia C Liu, et al.
Leukemia Research|October 6, 2020
Pregnancy outcomes, risk factors, and cell count trends in pregnant women with essential thrombocythemiaJoan How, Orly Leiva, Thomas Bogue, et al.
Blood Advances|January 7, 2026
Impact of Statin Use on Cardiovascular and Hematologic Outcomes Among Patients with Myeloproliferative NeoplasmsOrly Leiva, Steven Soo, Olivia C Liu, et al.
Blood Vessels, Thrombosis & Hemostasis|August 6, 2025
Cardiovascular risk factors in myeloproliferative neoplasms: associations with survival and thrombotic outcomesJoan How, Orly Leiva, Robert Redd, et al.
JACC. Cardiooncology|July 16, 2025
Beyond Thrombosis: Pulmonary Hypertension and Heart Failure in Patients With Myeloproliferative Neoplasms: JACC: CardioOncology State-of-the-Art ReviewOrly Leiva, Olivia Liu, Anthony Kanelidis, et al.
Pageof 5